Addition of a second opioid may improve opioid response in cancer pain: preliminary data
- 15 June 2004
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Supportive Care in Cancer
- Vol. 12 (11), 762-766
- https://doi.org/10.1007/s00520-004-0650-1
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Regulation of Opioid Receptor Trafficking and Morphine Tolerance by Receptor OligomerizationCell, 2002
- Accuracy in Equianalgesic Dosing: Conversion DilemmasJournal of Pain and Symptom Management, 2001
- Opioid Poorly-Responsive Cancer Pain. Part 2: Basic Mechanisms That Could Shift Dose Response for AnalgesiaJournal of Pain and Symptom Management, 2001
- Opioid use in cancer pain. Is a more liberal approach enhancing toxicity?Acta Anaesthesiologica Scandinavica, 1999
- Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer painPain, 1996
- Mechanisms of hyperalgesian and morphine tolerance: a current view of their possible interactionsPain, 1995
- Opioid rotation for toxicity reduction in terminal cancer patientsJournal of Pain and Symptom Management, 1995
- Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonistsPain, 1994
- The Edmonton staging system for cancer pain: preliminary reportPain, 1989
- A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancerPain, 1986